These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32418649)

  • 1. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Zhang AD; Su XH; Shi GF; Han C; Wang L; Liu H; Zhang J; Zhang RH
    Arch Med Res; 2020 Jul; 51(5):419-428. PubMed ID: 32418649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma.
    Chen H; Zhou L; Yang Y; Yang L; Chen L
    Med Sci Monit; 2018 Jun; 24():4183-4191. PubMed ID: 29915168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.
    Li C; Tan L; Liu X; Wang X; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Bi N; Deng L; Wang W; Zhang T; Ni W; Chang X; Han W; Gao L; Wang S; Xiao Z
    Thorac Cancer; 2021 Jun; 12(12):1831-1840. PubMed ID: 33949784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).
    Chen M; Liu X; Han C; Wang X; Zhao Y; Pang Q; Sun X; Li G; Zhang K; Li L; Qiao X; Lin Y; Chen J; Xiao Z
    BMC Cancer; 2020 Jan; 20(1):36. PubMed ID: 31941487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of induction chemotherapy for non-operable esophageal squamous cell carcinoma followed by concurrent chemoradiotherapy: a single-centre experience.
    Xiang G; Chai G; Lyu B; Li Z; Yin Y; Wang B; Pan Y; Shi M; Zhao L
    Radiol Oncol; 2024 Sep; 58(3):444-457. PubMed ID: 39287163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Chen M; Shen M; Lin Y; Liu P; Liu X; Li X; Li A; Yang R; Ni W; Zhou X; Zhang L; Xu B; Lin J; Chen J; Tian Y
    Radiat Oncol; 2018 Aug; 13(1):150. PubMed ID: 30111361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers.
    Huang C; Zhu Y; Li Q; Zhang W; Liu H; Zhang W; Hu Y; Yuan Y; Liu M
    Cancer Med; 2019 Jan; 8(1):28-39. PubMed ID: 30600600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
    Ren XJ; Wang L; Han C; Liu LL
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
    Chen F; Luo H; Xing L; Liang N; Xie J; Zhang J
    Thorac Cancer; 2018 Jan; 9(1):59-65. PubMed ID: 29024498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
    Wang J; Xiao L; Wang S; Pang Q; Wang J
    Front Oncol; 2021; 11():665231. PubMed ID: 34589418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
    Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
    Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
    Liu Y; Zheng Z; Li M; Zhang Y; Zhao F; Gong H; Lin H; Huang W; Chen X; Xu Z; Li X; Liu W; Cui Y; Zheng A; Li B
    Int J Cancer; 2022 Aug; 151(4):607-615. PubMed ID: 35419831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
    Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival comparision of three-dimensional radiotherapy alone with concurrent chemoradiotherapy for non-surgical esophageal carcinoma.
    Tan L; Xiao Z; Zhang H; Chen D; Feng Q; Zhou Z; Lv J; Liang J; Yin W
    Cancer Radiother; 2020 Feb; 24(1):21-27. PubMed ID: 32001131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study.
    Zhao Q; Hu G; Xiao W; Chen Y; Shen M; Tang Q; Ning X
    Medicine (Baltimore); 2017 Sep; 96(35):e7920. PubMed ID: 28858114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone in Esophageal Squamous Cell Carcinoma Induction chemotherapy in Esophageal Squamous Cell Carcinoma.
    Hosseini Toudeshki S; Garousi M; Arefpour AM; Fadavi P; Basi A; Foroughi A; Javadinia SA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1183-1188. PubMed ID: 38679976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma.
    Liu Q; Tu XH; Yu RX; Wen HY; Guo XG; Ma DY; Jiang KY; Tian D
    Cancer Med; 2024 Aug; 13(16):e70108. PubMed ID: 39161098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Yang X; Wang L; Du H; Lin B; Yi J; Wen X; Geng L; Du X
    Medicine (Baltimore); 2021 Jan; 100(3):e24328. PubMed ID: 33546064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method.
    Chen X; Zhu X; Liang Z; Li L; Qu S; Chen K; Pan X
    Onco Targets Ther; 2017; 10():2909-2921. PubMed ID: 28652773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.